22.418 articles found

Levodopa: past, present, and future.

Hauser RA.

Eur Neurol · 2008-09-09

DOI: 10.1159/000215875PMID: 19407449

Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis.

Baker WL, Silver D, White CM, Kluger J, Aberle J, Patel AA, Coleman CI.

Parkinsonism Relat Disord · 2008-09-06

DOI: 10.1016/j.parkreldis.2008.07.004PMID: 18774743

Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brian, the pharmaceutical compositions comprising them and their use in the treatment of Parkinson's disease

PIOT-GROSJEAN ODILE, BOCCIO DANIEL, BENAVIDES JESUS, HENIN YVETTE.

· 2008-09-05

Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease.

Fitzgerald P, Mandel A, Bolton AE, Sullivan AM, Nolan Y.

Behav Brain Res · 2008-09-04

DOI: 10.1016/j.bbr.2008.08.041PMID: 18817814

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.

Liu M, Hunter R, Nguyen XV, Kim HC, Bing G.

J Neurosci Res · 2008-09-01

DOI: 10.1002/jnr.21725PMID: 18500758

Nicotine and Parkinson's disease: implications for therapy.

Quik M, O'Leary K, Tanner CM.

Mov Disord · 2008-09-01

DOI: 10.1002/mds.21900PMID: 18683238

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.

Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.

Pharmacogenet Genomics · 2008-09-01

DOI: 10.1097/fpc.0b013e328306c2f2PMID: 18698234

[Cholinesterase inhibitors for the treatment of dementia in Parkinson's disease].

Check source for author details

Nervenarzt · 2008-09-01

DOI: 10.1007/s00115-008-2544-9PMID: 18704357

Treatment of atrial fibrillation and atrial flutter: Part II.

Aronow WS.

Cardiol Rev · 2008-09-01

DOI: 10.1097/crd.0b013e3181723694PMID: 18708824

Dopamine agonists in the treatment of non-motor symptoms of Parkinson's disease: depression.

Lemke MR.

Eur J Neurol · 2008-09-01

DOI: 10.1111/j.1468-1331.2008.02213.xPMID: 18702737

Anterocollis: clinical features and treatment options.

Papapetropoulos S, Tuchman A, Sengun C, Russell A, Mitsi G, Singer C.

Med Sci Monit · 2008-09-01

PMID: 18758411

Levodopa and executive performance in Parkinson's disease: a randomized study.

Pascual-Sedano B, Kulisevsky J, Barbanoj M, García-Sánchez C, Campolongo A, Gironell A, Pagonabarraga J, Gich I.

J Int Neuropsychol Soc · 2008-09-01

DOI: 10.1017/s1355617708081010PMID: 18764978